Patient presents with a ureteral stent in situ.  The stent placement was (initial placement date if known, otherwise state reason for unknown date, e.g., placed at outside facility, remote history).  The indication for stent placement was (indication, e.g., nephrolithiasis, ureteral stricture, postoperative urinary diversion).  Patient reports (patient-reported symptoms related to the stent, e.g., asymptomatic, mild flank discomfort, occasional hematuria).  On physical exam, (relevant physical exam findings, e.g., abdomen soft, nontender, no costovertebral angle tenderness).  Review of systems reveals (pertinent positives and negatives related to genitourinary function, e.g., denies dysuria, frequency, urgency).  Current medications include (list medications, especially those affecting coagulation or urinary tract function).  Plan includes (plan for stent management, e.g., scheduled stent removal on (date), monitoring for stent-related complications, patient education regarding stent care and potential complications).  Assessment:  Presence of ureteral stent,  (ICD-10 code Z98.81).  Differential diagnoses included (if applicable, list any alternative explanations for reported symptoms) but presence of stent confirmed by (method of confirmation, e.g., imaging, previous operative report).  Patient education provided regarding signs and symptoms of urinary tract infection, obstruction, and other stent-related complications. Follow-up scheduled as indicated.